| Year |
Citation |
Score |
| 2024 |
Haran S, Chindera K, Sabry M, Wilkinson N, Arora R, Zubiak A, Bartlett TE, Evans I, Jones A, Reisel D, Herzog C, Alkasalias T, Newman M, Kim J, Rådestad AF, ... ... Dubeau L, et al. Natural Killer Cell Dysfunction in Premenopausal Mutation Carriers: A Potential Mechanism for Ovarian Carcinogenesis. Cancers. 16. PMID 38539519 DOI: 10.3390/cancers16061186 |
0.322 |
|
| 2021 |
Yuan B, Yang J, Dubeau L, Hu Y, Li R. A Phosphotyrosine Switch in Estrogen Receptor β Is Required for Mouse Ovarian Function. Frontiers in Cell and Developmental Biology. 9: 649087. PMID 33898441 DOI: 10.3389/fcell.2021.649087 |
0.338 |
|
| 2020 |
Dong S, Khedro T, Ward P, Dubeau L, Yaghmour B, Siddiqi I, Yaghmour G. First reported case of BRAF V600E mutation in T-cell prolymphocytic leukaemia. British Journal of Haematology. PMID 32712959 DOI: 10.1111/Bjh.16992 |
0.333 |
|
| 2020 |
Widschwendter M, Dubeau L. Non-Surgical Cancer Risk Reduction in Mutation Carriers: Disabling the Remote Control. Cancers. 12. PMID 32120796 DOI: 10.3390/Cancers12030547 |
0.476 |
|
| 2020 |
Samanta S, Tamura S, Dubeau L, Mhawech-Fauceglia P, Miyagi Y, Kato H, Lieberman R, Buckanovich RJ, Lin YG, Neamati N. Clinicopathological significance of endoplasmic reticulum stress proteins in ovarian carcinoma. Scientific Reports. 10: 2160. PMID 32034256 DOI: 10.1038/S41598-020-59116-X |
0.377 |
|
| 2019 |
Markland FS, Swenson S, Minea R, Dubeau L. Abstract C032: A novel integrin-targeted therapeutic agent for ovarian cancer Molecular Cancer Therapeutics. DOI: 10.1158/1535-7163.Targ-19-C032 |
0.359 |
|
| 2018 |
Austria T, Marion C, Yu V, Widschwendter M, Hinton DR, Dubeau L. Mechanism of cytokinesis failure in ovarian cystadenomas with defective brca1 and p53 pathways. International Journal of Cancer. PMID 29978915 DOI: 10.1002/Ijc.31659 |
0.787 |
|
| 2018 |
Barzi A, Campan M, Petterson J, Du L, Long T, Dubeau L, Lenz H, Ward P. Assessment of microsatellite instability (MSI) in cell free DNA (cfDNA) of colorectal cancers (CRC) patients (pts). Journal of Clinical Oncology. 36: 672-672. DOI: 10.1200/Jco.2018.36.4_Suppl.672 |
0.354 |
|
| 2018 |
Bacher J, Halberg R, Ward P, Udho E, Murphy K, Uhr M, Dubeau L, Pettersson J, Storts D, Gallinger S, Buchanan D, Jenkins M, Lindor N, Eshleman J. Development of a pan-cancer biomarker panel for improved detection of MSI across all cancer types Annals of Oncology. 29: viii27-viii28. DOI: 10.1093/Annonc/Mdy269.088 |
0.366 |
|
| 2017 |
Samanta S, Tamura S, Dubeau L, Mhawech-Fauceglia P, Miyagi Y, Kato H, Lieberman R, Buckanovich RJ, Lin YG, Neamati N. Expression of protein disulfide isomerase family members correlates with tumor progression and patient survival in ovarian cancer. Oncotarget. 8: 103543-103556. PMID 29262583 DOI: 10.18632/Oncotarget.21569 |
0.447 |
|
| 2017 |
Shen J, Ha DP, Zhu G, Rangel DF, Kobielak A, Gill PS, Groshen S, Dubeau L, Lee AS. GRP78 haploinsufficiency suppresses acinar-to-ductal metaplasia, signaling, and mutant Kras-driven pancreatic tumorigenesis in mice. Proceedings of the National Academy of Sciences of the United States of America. PMID 28461470 DOI: 10.1073/Pnas.1616060114 |
0.327 |
|
| 2017 |
Lee AS, Brandhorst S, Rangel DF, Navarrete G, Cohen P, Longo VD, Chen J, Groshen S, Morgan TE, Dubeau L. Effects of Prolonged GRP78 Haploinsufficiency on Organ Homeostasis, Behavior, Cancer and Chemotoxic Resistance in Aged Mice. Scientific Reports. 7: 40919. PMID 28145503 DOI: 10.1038/Srep40919 |
0.342 |
|
| 2017 |
Lee AS, Shen J, Rangel D, Tseng C, Tsai YL, Ha DP, Zhao H, Dubeau L. Abstract SY13-03: GRP78/BiP: Cancer's comrade in crime Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Sy13-03 |
0.357 |
|
| 2016 |
Kiechl S, Schramek D, Widschwendter M, Fourkala EO, Zaikin A, Jones A, Jaeger B, Rack B, Janni W, Scholz C, Willeit J, Weger S, Mayr A, Teschendorff A, Rosenthal A, ... ... Dubeau L, et al. Aberrant regulation of RANKL/OPG in women at high risk of developing breast cancer. Oncotarget. PMID 28002811 DOI: 10.18632/Oncotarget.14013 |
0.42 |
|
| 2016 |
Bartlett TE, Chindera K, McDermott J, Breeze CE, Cooke WR, Jones A, Reisel D, Karegodar ST, Arora R, Beck S, Menon U, Dubeau L, Widschwendter M. Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution. Nature Communications. 7: 11620. PMID 27216078 DOI: 10.1038/Ncomms11620 |
0.478 |
|
| 2016 |
Shen J, Yao L, Lin YG, DeMayo FJ, Lydon JP, Dubeau L, Lee AS. Glucose-regulated protein 94 deficiency induces squamous cell metaplasia and suppresses PTEN-null driven endometrial epithelial tumor development. Oncotarget. PMID 26910913 DOI: 10.18632/Oncotarget.7450 |
0.437 |
|
| 2016 |
Hugen CM, Ward P, Petterson J, Dubeau L, Dempsey PW, Hu BR, Xu T, Quinn DI, Goldkorn A. Targeted next generation sequencing (NGS) of matched primary tumor, metastasis, circulating tumor cells (CTCs), and cell-free DNA (cfDNA) in a patient with advanced prostate cancer (PC). Journal of Clinical Oncology. 34: e23057-e23057. DOI: 10.1200/Jco.2016.34.15_Suppl.E23057 |
0.36 |
|
| 2015 |
Widschwendter M, Burnell M, Fraser L, Rosenthal AN, Philpott S, Reisel D, Dubeau L, Cline M, Pan Y, Yi PC, Gareth Evans D, Jacobs IJ, Menon U, Wood CE, Dougall WC. Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers. Ebiomedicine. 2: 1331-9. PMID 26629528 DOI: 10.1016/J.Ebiom.2015.08.037 |
0.427 |
|
| 2015 |
Liu Y, Yen HY, Austria T, Pettersson J, Peti-Peterdi J, Maxson R, Widschwendter M, Dubeau L. A Mouse Model That Reproduces the Developmental Pathways and Site Specificity of the Cancers Associated With the Human BRCA1 Mutation Carrier State. Ebiomedicine. 2: 1318-30. PMID 26629527 DOI: 10.1016/J.Ebiom.2015.08.034 |
0.542 |
|
| 2015 |
Dubeau L. Pathogenesis of serous, extra-uterine Müllerian epithelial cancer and therapeutic implications. Translational Cancer Research. 4: 3-13. PMID 26568913 DOI: 10.3978/J.Issn.2218-676X.2015.01.06 |
0.553 |
|
| 2015 |
Teschendorff AE, Lee SH, Jones A, Fiegl H, Kalwa M, Wagner W, Chindera K, Evans I, Dubeau L, Orjalo A, Horlings HM, Niederreiter L, Kaser A, Yang W, Goode EL, et al. HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer. Genome Medicine. 7: 108. PMID 26497652 DOI: 10.1186/S13073-015-0233-4 |
0.403 |
|
| 2015 |
Liu Y, Pike MC, Wu N, Lin YG, Mucowski S, Punj V, Tang Y, Yen HY, Stanczyk FZ, Enbom E, Austria T, Widschwendter M, Maxson R, Dubeau L. Brca1 Mutations Enhance Mouse Reproductive Functions by Increasing Responsiveness to Male-Derived Scent. Plos One. 10: e0139013. PMID 26488398 DOI: 10.1371/Journal.Pone.0139013 |
0.415 |
|
| 2015 |
Brandhorst S, Choi IY, Wei M, Cheng CW, Sedrakyan S, Navarrete G, Dubeau L, Yap LP, Park R, Vinciguerra M, Di Biase S, Mirzaei H, Mirisola MG, Childress P, Ji L, et al. A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan. Cell Metabolism. PMID 26094889 DOI: 10.1016/J.Cmet.2015.05.012 |
0.351 |
|
| 2015 |
Shen J, Lin YG, Dubeau L, Lee AS. Abstract LB-136: The role of ER chaperone GRP94 in endometrial cancer progression Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-136 |
0.398 |
|
| 2014 |
Palian BM, Rohira AD, Johnson SA, He L, Zheng N, Dubeau L, Stiles BL, Johnson DL. Maf1 is a novel target of PTEN and PI3K signaling that negatively regulates oncogenesis and lipid metabolism. Plos Genetics. 10: e1004789. PMID 25502566 DOI: 10.1371/Journal.Pgen.1004789 |
0.345 |
|
| 2014 |
Cho HY, Wang W, Jhaveri N, Lee DJ, Sharma N, Dubeau L, Schönthal AH, Hofman FM, Chen TC. NEO212, temozolomide conjugated to perillyl alcohol, is a novel drug for effective treatment of a broad range of temozolomide-resistant gliomas. Molecular Cancer Therapeutics. 13: 2004-17. PMID 24994771 DOI: 10.1158/1535-7163.Mct-13-0964 |
0.35 |
|
| 2014 |
Dubeau L, Drapkin R. Coming into focus: the nonovarian origins of ovarian cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology. viii28-viii35. PMID 24131966 DOI: 10.1093/Annonc/Mdt308 |
0.472 |
|
| 2014 |
Brandhorst S, Wei M, Navarre G, Dubeau L, Conti P, Morgan T, Longo VD. Abstract 4120: Periodic fasting mimicking diet started late in life reduces and delays carcinogenesis Cancer Research. 74: 4120-4120. DOI: 10.1158/1538-7445.Am2014-4120 |
0.411 |
|
| 2014 |
Marion CM, Yu V, Dubeau L. Abstract 2387: Interplay between Aurora A kinase and BRCA1 promotes genetic stability Cancer Research. 74: 2387-2387. DOI: 10.1158/1538-7445.Am2014-2387 |
0.813 |
|
| 2014 |
Austria T, Hinton D, Dubeau L. Abstract 1317: The metaphase checkpoint complex is controlled by events downstream to spindle assembly and microtubule attachment to the kinetochore Cancer Research. 74: 1317-1317. DOI: 10.1158/1538-7445.Am2014-1317 |
0.458 |
|
| 2013 |
Widschwendter M, Rosenthal AN, Philpott S, Rizzuto I, Fraser L, Hayward J, Intermaggio MP, Edlund CK, Ramus SJ, Gayther SA, Dubeau L, Fourkala EO, Zaikin A, Menon U, Jacobs IJ. The sex hormone system in carriers of BRCA1/2 mutations: a case-control study. The Lancet. Oncology. 14: 1226-32. PMID 24140203 DOI: 10.1016/S1470-2045(13)70448-0 |
0.431 |
|
| 2013 |
Matsuo K, Gray MJ, Yang DY, Srivastava SA, Tripathi PB, Sonoda LA, Yoo EJ, Dubeau L, Lee AS, Lin YG. The endoplasmic reticulum stress marker, glucose-regulated protein-78 (GRP78) in visceral adipocytes predicts endometrial cancer progression and patient survival. Gynecologic Oncology. 128: 552-9. PMID 23200913 DOI: 10.1016/J.Ygyno.2012.11.024 |
0.362 |
|
| 2012 |
Yen HY, Gabet Y, Liu Y, Martin A, Wu NL, Pike MC, Frenkel B, Maxson R, Dubeau L. Alterations in Brca1 expression in mouse ovarian granulosa cells have short-term and long-term consequences on estrogen-responsive organs. Laboratory Investigation; a Journal of Technical Methods and Pathology. 92: 802-11. PMID 22488153 DOI: 10.1038/Labinvest.2012.58 |
0.529 |
|
| 2012 |
Yu VM, Marion CM, Austria TM, Yeh J, Schönthal AH, Dubeau L. Role of BRCA1 in controlling mitotic arrest in ovarian cystadenoma cells. International Journal of Cancer. 130: 2495-504. PMID 21792894 DOI: 10.1002/Ijc.26309 |
0.803 |
|
| 2012 |
Liu Y, Yen H, Gabet Y, Wu N, Pike MC, Frenkel B, Maxson R, Dubeau L. Abstract 3279: Potential beneficial effects of the BRCA1 mutation carrier state on bone strength Cancer Research. 72: 3279-3279. DOI: 10.1158/1538-7445.Am2012-3279 |
0.47 |
|
| 2012 |
Marion CM, Yu V, Austria T, Dubeau L. Abstract 2038: Aurora A and BRCA1 cooperate to control cytokinesis failure leading to aneuploidy in ovarian cystadenoma cells Cancer Research. 72: 2038-2038. DOI: 10.1158/1538-7445.Am2012-2038 |
0.807 |
|
| 2011 |
Campan M, Moffitt M, Houshdaran S, Shen H, Widschwendter M, Daxenbichler G, Long T, Marth C, Laird-Offringa IA, Press MF, Dubeau L, Siegmund KD, Wu AH, Groshen S, Chandavarkar U, et al. Genome-scale screen for DNA methylation-based detection markers for ovarian cancer. Plos One. 6: e28141. PMID 22163280 DOI: 10.1371/Journal.Pone.0028141 |
0.39 |
|
| 2011 |
Lagos-Jaramillo VI, Press MF, Ricker CN, Dubeau L, Mai PL, Weitzel JN. Pathological characteristics of BRCA-associated breast cancers in Hispanics. Breast Cancer Research and Treatment. 130: 281-9. PMID 21604016 DOI: 10.1007/S10549-011-1570-7 |
0.392 |
|
| 2011 |
Muggia F, Safra T, Dubeau L. BRCA genes: lessons learned from experimental and clinical cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology. i7-10. PMID 21285156 DOI: 10.1093/Annonc/Mdq659 |
0.446 |
|
| 2011 |
Liu Y, Punj V, Hong H, Enbom E, Maxson R, Dubeau L. Abstract 2395: Effect of Brca1 knockout on gene expression in mouse ovarian granulosa cells Cancer Research. 71: 2395-2395. DOI: 10.1158/1538-7445.Am2011-2395 |
0.603 |
|
| 2011 |
Matsuo K, Srivastava S, Tripathi P, Sonoda L, Yang D, Yoo E, Pfaffenbach K, Dubeau L, Lee A, Lin Y. Visceral adipocyte glucose-regulated protein (GRP) 78 is an independent risk factor for endometrial cancer survival Gynecologic Oncology. 123: 433. DOI: 10.1016/J.Ygyno.2011.07.048 |
0.331 |
|
| 2011 |
Matsuo K, Srivastava S, Tripathi P, Sonoda L, Yoo E, Pfaffenbac K, Dubeau L, Lee A, Lin Y. Adiposity and endometrial cancer: The stress of excess Gynecologic Oncology. 120: S85. DOI: 10.1016/J.Ygyno.2010.12.202 |
0.328 |
|
| 2010 |
Hong H, Yen HY, Brockmeyer A, Liu Y, Chodankar R, Pike MC, Stanczyk FZ, Maxson R, Dubeau L. Changes in the mouse estrus cycle in response to BRCA1 inactivation suggest a potential link between risk factors for familial and sporadic ovarian cancer. Cancer Research. 70: 221-8. PMID 20028858 DOI: 10.1158/0008-5472.Can-09-3232 |
0.784 |
|
| 2010 |
Wang M, Ye R, Barron E, Baumeister P, Mao C, Luo S, Fu Y, Luo B, Dubeau L, Hinton DR, Lee AS. Essential role of the unfolded protein response regulator GRP78/BiP in protection from neuronal apoptosis. Cell Death and Differentiation. 17: 488-98. PMID 19816510 DOI: 10.1038/Cdd.2009.144 |
0.3 |
|
| 2010 |
Liu Y, Enbom E, Yen H, Maxson R, Dubeau L. Abstract 3262: Role of the mullerian ducts in the development of genito-urinary organs and coelomic epithelial tissues in female mice Cancer Research. 70: 3262-3262. DOI: 10.1158/1538-7445.Am10-3262 |
0.403 |
|
| 2010 |
Marion CM, Dubeau L, Yu V. Abstract 1068: Cooperation between BRCA1 and Aurora A kinase regulatesin vitrocrisis in epithelial cells derived from benign ovarian tumors Cancer Research. 70: 1068-1068. DOI: 10.1158/1538-7445.Am10-1068 |
0.797 |
|
| 2009 |
Widschwendter M, Apostolidou S, Jones AA, Fourkala EO, Arora R, Pearce CL, Frasco MA, Ayhan A, Zikan M, Cibula D, Iyibozkurt CA, Yavuz E, Hauser-Kronberger C, Dubeau L, Menon U, et al. HOXA methylation in normal endometrium from premenopausal women is associated with the presence of ovarian cancer: a proof of principle study. International Journal of Cancer. Journal International Du Cancer. 125: 2214-8. PMID 19621443 DOI: 10.1002/Ijc.24599 |
0.46 |
|
| 2009 |
Shao C, Lacey M, Dubeau L, Ehrlich M. Hemimethylation footprints of DNA demethylation in cancer. Epigenetics. 4: 165-75. PMID 19287214 DOI: 10.4161/Epi.4.3.8277 |
0.343 |
|
| 2008 |
Yoo CB, Chuang JC, Byun HM, Egger G, Yang AS, Dubeau L, Long T, Laird PW, Marquez VE, Jones PA. Long-term epigenetic therapy with oral zebularine has minimal side effects and prevents intestinal tumors in mice. Cancer Prevention Research (Philadelphia, Pa.). 1: 233-40. PMID 19138966 DOI: 10.1158/1940-6207.Capr-07-0008 |
0.347 |
|
| 2008 |
Dubeau L. The cell of origin of ovarian epithelial tumours. The Lancet. Oncology. 9: 1191-7. PMID 19038766 DOI: 10.1016/S1470-2045(08)70308-5 |
0.457 |
|
| 2008 |
Dubeau L. BRCA1-induced ovarian oncogenesis. Advances in Experimental Medicine and Biology. 622: 89-97. PMID 18546621 DOI: 10.1007/978-0-387-68969-2_8 |
0.429 |
|
| 2008 |
Dong D, Ni M, Li J, Xiong S, Ye W, Virrey JJ, Mao C, Ye R, Wang M, Pen L, Dubeau L, Groshen S, Hofman FM, Lee AS. Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development. Cancer Research. 68: 498-505. PMID 18199545 DOI: 10.1158/0008-5472.Can-07-2950 |
0.451 |
|
| 2007 |
Yu J, Roy D, Brockmeyer AD, Dubeau L. Increased chromosomal stability in cultures of ovarian tumours of low malignant potential compared to cystadenomas. British Journal of Cancer. 96: 1908-13. PMID 17519898 DOI: 10.1038/Sj.Bjc.6603817 |
0.715 |
|
| 2007 |
Shelbourne PF, Keller-McGandy C, Bi WL, Yoon SR, Dubeau L, Veitch NJ, Vonsattel JP, Wexler NS, Arnheim N, Augood SJ. Triplet repeat mutation length gains correlate with cell-type specific vulnerability in Huntington disease brain. Human Molecular Genetics. 16: 1133-42. PMID 17409200 DOI: 10.1093/Hmg/Ddm054 |
0.374 |
|
| 2007 |
Kumar SR, Masood R, Spannuth WA, Singh J, Scehnet J, Kleiber G, Jennings N, Deavers M, Krasnoperov V, Dubeau L, Weaver FA, Sood AK, Gill PS. The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome. British Journal of Cancer. 96: 1083-91. PMID 17353927 DOI: 10.1038/Sj.Bjc.6603642 |
0.503 |
|
| 2006 |
Ehrlich M, Woods CB, Yu MC, Dubeau L, Yang F, Campan M, Weisenberger DJ, Long T, Youn B, Fiala ES, Laird PW. Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors. Oncogene. 25: 2636-45. PMID 16532039 DOI: 10.1038/Sj.Onc.1209145 |
0.383 |
|
| 2005 |
Nishiyama R, Qi L, Tsumagari K, Weissbecker K, Dubeau L, Champagne M, Sikka S, Nagai H, Ehrlich M. A DNA repeat, NBL2, is hypermethylated in some cancers but hypomethylated in others. Cancer Biology & Therapy. 4: 440-8. PMID 15846090 DOI: 10.4161/Cbt.4.4.1622 |
0.452 |
|
| 2005 |
Chodankar R, Kwang S, Sangiorgi F, Hong H, Yen HY, Deng C, Pike MC, Shuler CF, Maxson R, Dubeau L. Cell-nonautonomous induction of ovarian and uterine serous cystadenomas in mice lacking a functional Brca1 in ovarian granulosa cells. Current Biology : Cb. 15: 561-5. PMID 15797026 DOI: 10.1016/J.Cub.2005.01.052 |
0.799 |
|
| 2005 |
Grunau C, Sanchez C, Ehrlich M, van der Bruggen P, Hindermann W, Rodriguez C, Krieger S, Dubeau L, Fiala E, De Sario A. Frequent DNA hypomethylation of human juxtacentromeric BAGE loci in cancer. Genes, Chromosomes & Cancer. 43: 11-24. PMID 15704127 DOI: 10.1002/Gcc.20155 |
0.41 |
|
| 2004 |
Dong D, Dubeau L, Bading J, Nguyen K, Luna M, Yu H, Gazit-Bornstein G, Gordon EM, Gomer C, Hall FL, Gambhir SS, Lee AS. Spontaneous and controllable activation of suicide gene expression driven by the stress-inducible grp78 promoter resulting in eradication of sizable human tumors. Human Gene Therapy. 15: 553-61. PMID 15212714 DOI: 10.1089/104303404323142006 |
0.436 |
|
| 2004 |
Nouriani M, Bahador A, Berek JS, Cheng JP, Chi DS, Cliby WA, Del Priore G, Dodson MK, Duggan BD, Gershenson DM, Lentz SE, Penson RT, Robinson WR, Rodriguez M, Roman LD, ... ... Dubeau L, et al. Detection of residual subclinical ovarian carcinoma after completion of adjuvant chemotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 2681-6. PMID 15102671 DOI: 10.1158/1078-0432.Ccr-0523-03 |
0.322 |
|
| 2004 |
Bayrak A, Chodankar R, Stanczyk FZ, Paulson RJ, Dubeau L. Effect of BRCA1 on ovarian follicular and corpus luteum activity Fertility and Sterility. 81: 14. DOI: 10.1016/J.Fertnstert.2004.02.029 |
0.76 |
|
| 2003 |
Blumenthal M, Kardosh A, Dubeau L, Borok Z, Schönthal AH. Suppression of the transformed phenotype and induction of differentiation-like characteristics in cultured ovarian tumor cells by chronic treatment with progesterone. Molecular Carcinogenesis. 38: 160-9. PMID 14639655 DOI: 10.1002/Mc.10155 |
0.53 |
|
| 2003 |
Velicescu M, Yu J, Herbert BS, Shay JW, Granada E, Dubeau L. Aneuploidy and telomere attrition are independent determinants of crisis in SV40-transformed epithelial cells Cancer Research. 63: 5813-5820. PMID 14522904 |
0.686 |
|
| 2003 |
Johnson SA, Dubeau L, White RJ, Johnson DL. The TATA-binding protein as a regulator of cellular transformation. Cell Cycle (Georgetown, Tex.). 2: 442-4. PMID 12963838 DOI: 10.4161/Cc.2.5.493 |
0.308 |
|
| 2003 |
Yoon SR, Dubeau L, de Young M, Wexler NS, Arnheim N. Huntington disease expansion mutations in humans can occur before meiosis is completed. Proceedings of the National Academy of Sciences of the United States of America. 100: 8834-8. PMID 12857955 DOI: 10.1073/Pnas.1331390100 |
0.378 |
|
| 2003 |
Johnson SA, Dubeau L, Kawalek M, Dervan A, Schönthal AH, Dang CV, Johnson DL. Increased expression of TATA-binding protein, the central transcription factor, can contribute to oncogenesis. Molecular and Cellular Biology. 23: 3043-51. PMID 12697807 DOI: 10.1128/Mcb.23.9.3043-3051.2003 |
0.382 |
|
| 2002 |
Velicescu M, Dubeau L. p53: a key player in the telomere dynamics. Cancer Biology & Therapy. 1: 518-9. PMID 12496480 DOI: 10.4161/Cbt.1.5.168 |
0.379 |
|
| 2002 |
Chen C, Petitclerc E, Zhou H, Brooks PC, Sun T, Yu MC, Zheng W, Dubeau L. Effect of reproductive hormones on ovarian epithelial tumors: II. Effect on angiogenic activity. Cancer Biology & Therapy. 1: 307-12. PMID 12432284 DOI: 10.4161/Cbt.87 |
0.438 |
|
| 2002 |
Zhou H, Luo MP, Schönthal AH, Pike MC, Stallcup MR, Blumenthal M, Zheng W, Dubeau L. Effect of reproductive hormones on ovarian epithelial tumors: I. Effect on cell cycle activity. Cancer Biology & Therapy. 1: 300-6. PMID 12432283 DOI: 10.4161/Cbt.86 |
0.45 |
|
| 2002 |
Yu J, Dubeau L. Telomerase and malignant transformation. Cancer Treatment and Research. 107: 213-28. PMID 11775451 DOI: 10.1007/978-1-4757-3587-1_9 |
0.68 |
|
| 1999 |
Wan M, Sun T, Vyas R, Zheng J, Granada E, Dubeau L. Suppression of tumorigenicity in human ovarian cancer cell lines is controlled by a 2 cM fragment in chromosomal region 6q24-q25. Oncogene. 18: 1545-51. PMID 10102624 DOI: 10.1038/Sj.Onc.1202476 |
0.351 |
|
| 1999 |
Dubeau L. The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes? Gynecologic Oncology. 72: 437-42. PMID 10053122 DOI: 10.1006/Gyno.1998.5275 |
0.454 |
|
| 1999 |
Qu G, Dubeau L, Narayan A, Yu MC, Ehrlich M. Satellite DNA hypomethylation vs. overall genomic hypomethylation in ovarian epithelial tumors of different malignant potential. Mutation Research. 423: 91-101. PMID 10029684 DOI: 10.1016/S0027-5107(98)00229-2 |
0.393 |
|
| 1999 |
McCluskey LL, Chen C, Delgadillo E, Felix JC, Muderspach LI, Dubeau L. Differences in p16 gene methylation and expression in benign and malignant ovarian tumors. Gynecologic Oncology. 72: 87-92. PMID 9889036 DOI: 10.1006/Gyno.1998.5235 |
0.394 |
|
| 1998 |
Duggan BD, Dubeau L. Genetics and biology of gynecologic cancer. Current Opinion in Oncology. 10: 439-46. PMID 9800115 DOI: 10.1097/00001622-199809000-00012 |
0.396 |
|
| 1998 |
Zempolich KA, Dubeau L. Telomerase and cancer management: silver bullet or fool's gold? Gynecologic Oncology. 68: 143-4. PMID 9514814 DOI: 10.1006/Gyno.1998.4948 |
0.317 |
|
| 1998 |
Duggan BD, Wan M, Yu MC, Roman LD, Muderspach LI, Delgadillo E, Li WZ, Martin SE, Dubeau L. Detection of ovarian cancer cells: comparison of a telomerase assay and cytologic examination. Journal of the National Cancer Institute. 90: 238-42. PMID 9462682 DOI: 10.1093/Jnci/90.3.238 |
0.5 |
|
| 1998 |
Luo MP, Gomperts B, Imren S, DeClerck YA, Ito M, Velicescu M, Felix JC, Dubeau L. Establishment of long-term in vitro cultures of human ovarian cystadenomas and LMP tumors and examination of their spectrum of expression of matrix-degrading proteinases. Gynecologic Oncology. 67: 277-84. PMID 9441775 DOI: 10.1006/Gyno.1997.4880 |
0.381 |
|
| 1997 |
McCluskey LL, Dubeau L. Biology of ovarian cancer. Current Opinion in Oncology. 9: 465-70. PMID 9327225 DOI: 10.1097/00001622-199709050-00011 |
0.476 |
|
| 1997 |
Wan M, Li WZ, Duggan BD, Felix JC, Zhao Y, Dubeau L. Telomerase activity in benign and malignant epithelial ovarian tumors. Journal of the National Cancer Institute. 89: 437-41. PMID 9091645 DOI: 10.1093/Jnci/89.6.437 |
0.363 |
|
| 1997 |
Cheng P, Schmutte C, Cofer KF, Felix JC, Yu MC, Dubeau L. Alterations in DNA methylation are early, but not initial, events in ovarian tumorigenesis. British Journal of Cancer. 75: 396-402. PMID 9020485 DOI: 10.1038/Bjc.1997.64 |
0.355 |
|
| 1996 |
Wan M, Cofer KF, Dubeau L. WAF1/CIP1 structural abnormalities do not contribute to cell cycle deregulation in ovarian cancer. British Journal of Cancer. 73: 1398-400. PMID 8645586 DOI: 10.1038/Bjc.1996.265 |
0.472 |
|
| 1996 |
Cheng PC, Gosewehr JA, Kim TM, Velicescu M, Wan M, Zheng J, Felix JC, Cofer KF, Luo P, Biela BH, Godorov G, Dubeau L. Potential role of the inactivated X chromosome in ovarian epithelial tumor development. Journal of the National Cancer Institute. 88: 510-8. PMID 8606379 DOI: 10.1093/Jnci/88.8.510 |
0.41 |
|
| 1995 |
Zheng J, Benedict WF, Xu HJ, Hu SX, Kim TM, Velicescu M, Wan M, Cofer KF, Dubeau L. Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas. Journal of the National Cancer Institute. 87: 1146-53. PMID 7674319 DOI: 10.1093/Jnci/87.15.1146 |
0.4 |
|
| 1995 |
Bellacosa A, de Feo D, Godwin AK, Bell DW, Cheng JQ, Altomare DA, Wan M, Dubeau L, Scambia G, Masciullo V, Ferrandina G, Benedetti Panici P, Mancuso S, Neri G, Testa JR. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. International Journal of Cancer. 64: 280-5. PMID 7657393 DOI: 10.1002/Ijc.2910640412 |
0.481 |
|
| 1994 |
Wan M, Zweizig S, Dablaing G, Zheng J, Velicescu M, Dubeau L. 3 distinct regions of chromosome-6 are targets of loss of heterozygosity in human ovarian carcinomas. International Journal of Oncology. 5: 1043-8. PMID 21559678 DOI: 10.3892/Ijo.5.5.1043 |
0.315 |
|
| 1990 |
Weiss RE, Liu BC, Ahlering T, Dubeau L, Droller MJ. Mechanisms of human bladder tumor invasion: role of protease cathepsin B. The Journal of Urology. 144: 798-804. PMID 2201799 DOI: 10.1016/S0022-5347(17)39595-2 |
0.356 |
|
| 1989 |
Shaw KJ, Do YS, Kjos S, Anderson PW, Shinagawa T, Dubeau L, Hsueh WA. Human decidua is a major source of renin. The Journal of Clinical Investigation. 83: 2085-92. PMID 2656762 DOI: 10.1172/Jci114121 |
0.339 |
|
| 1989 |
Ehlen T, Dubeau L. Detection of ras point mutations by polymerase chain reaction using mutation-specific, inosine-containing oligonucleotide primers. Biochemical and Biophysical Research Communications. 160: 441-7. PMID 2655589 DOI: 10.1016/0006-291X(89)92452-2 |
0.319 |
|
| Show low-probability matches. |